Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis [INTERVENTIONAL]

CONCLUSIONS:
Overall, the incidence of delayed cerebral ischemia seems not to be significantly reduced among the antiplatelet therapy group. However, delayed cerebral ischemia tended to be lower among subjects with both long-term antiplatelet therapy and endovascular treatment and antiplatelet administration. Poor outcome and mortality rates were significantly reduced among the antiplatelet therapy group.

Source: American Journal of Neuroradiology - July 7, 2019 Category: Radiology Authors: Cagnazzo, F., Derraz, I., Lefevre, P.- H., Gascou, G., Dargazanli, C., Riquelme, C., Perrini, P., di Carlo, D., Bonafe, A., Costalat, V. Tags: INTERVENTIONAL Source Type: research